Extracellular vesicle-mediated suicide mRNA/protein delivery inhibits glioblastoma tumor growth in vivo

E. P. Erkan, D. Senfter, S. Madlener, G. Jungwirth, T. Ströbel, Nurten Saydam, Okay Saydam

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Extracellular vesicles (EVs) are considered as important mediators of intercellular communication, which carry a diverse repertoire of genetic information between cells. This feature of EVs can be used and improved to advance their therapeutic potential. We have previously shown that genetically engineered EVs carrying the suicide gene mRNA and protein-cytosine deaminase (CD) fused to uracil phosphoribosyltransferase (UPRT)-inhibited schwannoma tumor growth in vivo. To further examine whether this approach can be applied to other cancer types, we established a subcutaneous xenograft glioblastoma tumor model in mice, as glioblastoma represents the most common primary brain tumor, which is highly aggressive compared with the original schwannoma tumor model. U87-MG glioblastoma cells were implanted into the flanks of nude SCID mice, and the animals were intratumorally injected with the EVs isolated from the cells expressing EGFP or CD-UPRT. After the intraperitoneal administration of the prodrug 5-fluorocytosine, the tumor growth was assessed by regular caliper measurements. Our data revealed that the treatment with the CD-UPRT-enriched EVs significantly reduced the tumor growth in mice. Taken together, our findings suggest that EVs uploaded with therapeutic CD-UPRT mRNA/protein may be a useful tool for glioblastoma treatment.

Original languageEnglish (US)
Pages (from-to)38-44
Number of pages7
JournalCancer gene therapy
Volume24
Issue number1
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

uracil phosphoribosyltransferase
Glioblastoma
Cytosine Deaminase
Suicide
Messenger RNA
Growth
Neoplasms
Proteins
Neurilemmoma
Flucytosine
SCID Mice
Prodrugs
Heterografts
Nude Mice
Brain Neoplasms
Extracellular Vesicles
Therapeutics

Cite this

Extracellular vesicle-mediated suicide mRNA/protein delivery inhibits glioblastoma tumor growth in vivo. / Erkan, E. P.; Senfter, D.; Madlener, S.; Jungwirth, G.; Ströbel, T.; Saydam, Nurten; Saydam, Okay.

In: Cancer gene therapy, Vol. 24, No. 1, 01.01.2017, p. 38-44.

Research output: Contribution to journalArticle

Erkan, E. P. ; Senfter, D. ; Madlener, S. ; Jungwirth, G. ; Ströbel, T. ; Saydam, Nurten ; Saydam, Okay. / Extracellular vesicle-mediated suicide mRNA/protein delivery inhibits glioblastoma tumor growth in vivo. In: Cancer gene therapy. 2017 ; Vol. 24, No. 1. pp. 38-44.
@article{5e802186b77a424ea6570d32a128a5da,
title = "Extracellular vesicle-mediated suicide mRNA/protein delivery inhibits glioblastoma tumor growth in vivo",
abstract = "Extracellular vesicles (EVs) are considered as important mediators of intercellular communication, which carry a diverse repertoire of genetic information between cells. This feature of EVs can be used and improved to advance their therapeutic potential. We have previously shown that genetically engineered EVs carrying the suicide gene mRNA and protein-cytosine deaminase (CD) fused to uracil phosphoribosyltransferase (UPRT)-inhibited schwannoma tumor growth in vivo. To further examine whether this approach can be applied to other cancer types, we established a subcutaneous xenograft glioblastoma tumor model in mice, as glioblastoma represents the most common primary brain tumor, which is highly aggressive compared with the original schwannoma tumor model. U87-MG glioblastoma cells were implanted into the flanks of nude SCID mice, and the animals were intratumorally injected with the EVs isolated from the cells expressing EGFP or CD-UPRT. After the intraperitoneal administration of the prodrug 5-fluorocytosine, the tumor growth was assessed by regular caliper measurements. Our data revealed that the treatment with the CD-UPRT-enriched EVs significantly reduced the tumor growth in mice. Taken together, our findings suggest that EVs uploaded with therapeutic CD-UPRT mRNA/protein may be a useful tool for glioblastoma treatment.",
author = "Erkan, {E. P.} and D. Senfter and S. Madlener and G. Jungwirth and T. Str{\"o}bel and Nurten Saydam and Okay Saydam",
year = "2017",
month = "1",
day = "1",
doi = "10.1038/cgt.2016.78",
language = "English (US)",
volume = "24",
pages = "38--44",
journal = "Cancer Gene Therapy",
issn = "0929-1903",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Extracellular vesicle-mediated suicide mRNA/protein delivery inhibits glioblastoma tumor growth in vivo

AU - Erkan, E. P.

AU - Senfter, D.

AU - Madlener, S.

AU - Jungwirth, G.

AU - Ströbel, T.

AU - Saydam, Nurten

AU - Saydam, Okay

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Extracellular vesicles (EVs) are considered as important mediators of intercellular communication, which carry a diverse repertoire of genetic information between cells. This feature of EVs can be used and improved to advance their therapeutic potential. We have previously shown that genetically engineered EVs carrying the suicide gene mRNA and protein-cytosine deaminase (CD) fused to uracil phosphoribosyltransferase (UPRT)-inhibited schwannoma tumor growth in vivo. To further examine whether this approach can be applied to other cancer types, we established a subcutaneous xenograft glioblastoma tumor model in mice, as glioblastoma represents the most common primary brain tumor, which is highly aggressive compared with the original schwannoma tumor model. U87-MG glioblastoma cells were implanted into the flanks of nude SCID mice, and the animals were intratumorally injected with the EVs isolated from the cells expressing EGFP or CD-UPRT. After the intraperitoneal administration of the prodrug 5-fluorocytosine, the tumor growth was assessed by regular caliper measurements. Our data revealed that the treatment with the CD-UPRT-enriched EVs significantly reduced the tumor growth in mice. Taken together, our findings suggest that EVs uploaded with therapeutic CD-UPRT mRNA/protein may be a useful tool for glioblastoma treatment.

AB - Extracellular vesicles (EVs) are considered as important mediators of intercellular communication, which carry a diverse repertoire of genetic information between cells. This feature of EVs can be used and improved to advance their therapeutic potential. We have previously shown that genetically engineered EVs carrying the suicide gene mRNA and protein-cytosine deaminase (CD) fused to uracil phosphoribosyltransferase (UPRT)-inhibited schwannoma tumor growth in vivo. To further examine whether this approach can be applied to other cancer types, we established a subcutaneous xenograft glioblastoma tumor model in mice, as glioblastoma represents the most common primary brain tumor, which is highly aggressive compared with the original schwannoma tumor model. U87-MG glioblastoma cells were implanted into the flanks of nude SCID mice, and the animals were intratumorally injected with the EVs isolated from the cells expressing EGFP or CD-UPRT. After the intraperitoneal administration of the prodrug 5-fluorocytosine, the tumor growth was assessed by regular caliper measurements. Our data revealed that the treatment with the CD-UPRT-enriched EVs significantly reduced the tumor growth in mice. Taken together, our findings suggest that EVs uploaded with therapeutic CD-UPRT mRNA/protein may be a useful tool for glioblastoma treatment.

UR - http://www.scopus.com/inward/record.url?scp=85006295096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006295096&partnerID=8YFLogxK

U2 - 10.1038/cgt.2016.78

DO - 10.1038/cgt.2016.78

M3 - Article

C2 - 27982017

AN - SCOPUS:85006295096

VL - 24

SP - 38

EP - 44

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

SN - 0929-1903

IS - 1

ER -